Basics Bio-Techne Corp Bio-Techne Corp and is a biotechnology company which develops, manufactures and sells biotechnology reagents, instruments and clinical diagnostic products. IPO Date: March 1, 1989 Sector: Healthcare Industry: Life Sciences Tools and Services Market Cap: $7.62B Activated in VL: True Average Daily Range Avg Daily Range: $1.49 | 1.14% Avg Daily Range (30 D): $0.85 | 1.71% Avg Daily Range (90 D): $1.22 | 2.14% Institutional Daily Volume Avg Daily Volume: .26M Avg Daily Volume (30 D): 1.82M Avg Daily Volume (90 D): 1.73M Trade Size Avg Trade Size (Sh.): 63 Avg Trade Size (Sh.) (30 D): 57 Avg Trade Size (Sh.) (90 D): 58 Institutional Trades Total Inst.Trades: 6,663 Avg Inst. Trade: $4.92M Avg Inst. Trade (30 D): $5.59M Avg Inst. Trade (90 D): $4.57M Avg Inst. Trade Volume: .32M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $8.36M Avg Closing Trade (30 D): $23.47M Avg Closing Trade (90 D): $18.09M Avg Closing Volume: 407.93K     News May 7, 2025 @ 10:30 AM BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCH... Source: Prnewswire Apr 8, 2025 @ 8:48 AM Minimal Residual Disease Testing Market Forecast R... Source: Researchandmarkets.Com Mar 12, 2025 @ 3:50 PM Complement C4 Antibody Market Research 2025: Growi... Source: Researchandmarkets.Com Feb 5, 2025 @ 11:30 AM Bio-Techne Declares Dividend Source: Prnewswire Jan 24, 2025 @ 9:45 AM Spatial Proteomics Market Report and Competitive L... Source: Researchandmarkets.Com Financials   TTM Q3 2025 Q2 2025 Basic EPS $.84 $.14 Diluted EPS $.83 $.14 Revenue $ 1.21B $ 316.18M $ Gross Profit $ 794.81M $ 214.56M $ Net Income / Loss $ 131.67M $ 22.59M $ 34.89M Operating Income / Loss $ 171.94M $ 38.71M $ Cost of Revenue $ 413.96M $ 101.63M $ Net Cash Flow $ -3.09M $ $ PE Ratio 0.00     Splits Nov 30, 2022:   4:1 Nov 10, 2022:   4:1 Dec 04, 2000:   2:1